Earnings Feed
Start Free
BIOJECT MEDICAL TECHNOLOGIES INC·4

Dec 8, 8:56 PM ET

Makar Ralph 4

4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Dec 8, 2009

Insider Transaction Report

Form 4
Period: 2009-10-01
BIOJECT MEDICAL TECHNOLOGIES INCBJCT
Makar Ralph
CEO/President
Transactions
  • Exercise/Conversion

    Restricted Stock Unit

    2009-10-01−33,333→ 357,601 total
    From: 2009-10-01→ BJCT Common Stock (33,333 underlying)
  • Exercise/Conversion

    BJCT Common Stock

    2009-10-01+33,333→ 344,034 total
Holdings

  • BJCT Common Stock

    (indirect: By 401(k))
    86,916
Footnotes (5)
  • [F1]1/3 vesting per Executive Employment Agreement date October 1, 2007.
  • [F2]Includes 15,000 ESPP shares funded 5/15/09.
  • [F3]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
  • [F4]No expiration date.
  • [F5]Includes Series F Preferred Stock 67,600, Warrant (right-to-buy) 6,667, Option (right-to-buy) 150,000 Restricted Stock Unit 133,334.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT